BD Diagnostics, Bruker Partner on Microbial Identification Technologies | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BD Diagnostics and Bruker Daltonics jointly announced today a co-development and co-marketing agreement for microbial identification technologies.

The firms said that they will promote an emerging, integrated approach to bacterial and fungal identification and antimicrobial susceptibility testing through a combination of their technologies. The collaboration will combine Bruker's MALDI Biotyper microbial identification system with BD's Phoenix Microbiology System.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.

Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.